Upload Avatar (500 x 500)
Yong Shen
yongshen@ustc.edu.cn
English, Chinese
Anhui
University of Science and Technology of China
Life Sciences
  • 1983 - Bachelor's degree in Human and Animal Physiology: Nanjing University
  • 1986 - Master's degree in Physiology: Shanghai Institute of Physiology, Chinese Academy of Sciences
  • 1989 - PhD in Psychobiology and Neuroscience: State University of New York
  • 1993 - Joined Abbott Labs as Senior Molecular Neuropharmacologist and Group Leader
  • 1997 - Director and Senior Scientist at Sun Health Research Institute, Arizona
  • 2000 - Director of Hardman Laboratory for Molecular and Cellular Neurobiology
  • 2006 - Co-Director of SunHealth Asia-Pacific Medical Research Center
  • 2010 - Director at Roskamp Institute, Florida
  • Zenith Award in Alzheimer's Disease
  • Outstanding Contributor to Alzheimer Research
  • 2009 - Changjiang Scholar Award Program
Molecular mechanisms of brain function and diseases
Molecular pathology and drug discovery for neurodegenerative and psychiatric diseases
Early clinical diagnostic markers for brain diseases
  • Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease., Yang LB, Lindholm K, Yan R, Citron M, Xia W, Beach T, Sue L, Wong P, Price D, Li R, Shen Y., 2003
  • Aβ load is correlated with elevated BACE activity in sporadic Alzheimer patients., Li R, Yang LB, Lindholm K, Yan R, Citron M, Beach T, Sue L, Subbagh M, Cai H, Wong P, Price D, Shen Y., 2004
  • TNF death receptor signaling cascade is required for amyloid-protein induced neuron death., Li R., Lindholm K, Yang LB, Konishi Y, Hampel H, Zhang, D. Shen Y., 2004
  • Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model., Yue X, Lu M, Lancaster T, Cao P, Honda S, Staufenbiel M, Harada N, Zhong Z, Shen Y, Li R., 2005
  • High Levels of β-Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive Impairment, the early stage of Alzheimer’s Disease., Zhong, Z., Ewers, M., Teipel, S., Büger, K., Wallin, A., Blennow, K., Hampel, H., and Shen Y., 2007
  • Deletion of TNF death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer’s mice., HeP, ZhongZ, LindholmK, BerningL, LeeW, LemereC, StaufenbielM, LiR and Shen Y., 2007
  • Depletion of GGA3 stabilizes BACE and enhances β-secretase activity., Tesco G, Koh YH, Kang EL, Cameron AN, Das S, Sena-Esteves M, Hiltunen M, Yang SH, Zhong Z, Shen Y, Simpkins JW, Tanzi RE., 2007
  • Increased CSF-BACE1 activity is associated with ApoE-ε4 genotype in subjects with mild cognitive impairment (MCI) and Alzheimer's disease., Ewers M, Zhong Z, Bürger K, Wallin A, Blennow K, Teipel SJ, Shen Y, Hampel H., 2008
  • Interruption of β-catenin signaling reduces neurogenesis in Alzheimer’s disease’s brains., He, P. and Shen Y., 2009
  • A specific ELISA for measuring amyloid β-protein oligomers in human plasma and the brains of Alzheimer patients., Xia W., Yang T., Imelda M. Smith I. M., Shen Y., Walsh D. M. and Selkoe, D. J., 2009
  • Acetylation of tau inhibits Its degradation and contributes to tauopathy., Min S-W, Cho S-H, Zhou Y, Schroeder S, Haroutunian V, Seeley WW, Huang EJ, Shen Y, Masliah E, Mukherjee C, Meyers D, Cole PA, Ott M, Li Gan L., 2010
  • Genetic Deletion of TNF Receptor Suppresses Excitatory Synaptic Transmission via Reducing AMPA Receptor Synaptic Localization in Cortical Neurons., HeP, LiuQ, WuJ and Shen Y., 2011
  • Depletion of GGA1 and GGA3 mediates post-injury elevation of BACE1., Walker KR, Kang EL, Whalen MJ, Shen Y and Tesco G., 2012
  • Bid Signal Pathway Components are identified in the Temporal Cortex in Brains with Parkinson’s disease dementia., JiangH, HeP, AdlerCH,ShillH,BeachTG, Li, R, and ShenY., 2012
  • β-secretase: Its Biology as a Therapeutic Target in Diseases., Wang H, Li R and Shen Y., 2013
  • Long-term treatment of TNF inhibitor, thalidomide, ameliorates Alzheimer-like pathology through inhibition of β-secretasein a mouse model of Alzheimer’s disease., HeP, ChengX, StaufenbielM, LiR and Shen Y., 2013
  • MicroRNA-205 regulates the Expression of Parkinson’s disease-related Leucine-rich Repeat Kinase 2 Protein., Cho HJ, Jin SM, Ding J, Xie C, Yu J, Parisiadou L, Sun L, Vancraenenbroeck R, Lobbestael E, Baekelandt V, Taymans J-M, He P, Troncoso J, Shen Y, Cai H., 2013
  • Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy., Cheng X, He P, Yao H, Dong Q, Li R, Shen Y., 2014
  • Genetic deletion of TNFRII gene enhances the Alzheimer-like pathology in an APP transgenic mouse model via reduction of phosphorylated IκBα., Jiang H, He P, Xie J, Staufenbiel M, Li R, Shen Y., 2014
  • Deficiency of GDNF receptor GFRα1 in Alzheimer Neurons Results In Neuronal Death., KonishiY, YangLB, HeP, LindholmK, LuB, Li Rand Shen Y., 2014
  • Targeting TNF: A therapeutic strategy for Alzheimer’s disease., Cheng X, Shen Y and Li R., 2014
Neurodegenerative Diseases Psychiatric Diseases Molecular Mechanisms Gene Expression Drug Discovery Clinical Diagnostics Alzheimer'S Parkinson'S Neuroimmunology Brain Function

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.